About Precision Biomonitoring
Precision Biomonitoring is a company based in Ontario (United States) founded in 2016 by Mario Thomas was acquired by SQI Diagnostics in February 2022. Precision Biomonitoring has raised $5 million across 1 funding round from investors including NGen and SQI Diagnostics. Precision Biomonitoring offers products and services including Game Bài, Slots Game, Live Game, Bắn Cá, and Thể Thao. Precision Biomonitoring operates in a competitive market with competitors including DermTech, NeuMoDx, Biocartis, Biomeme and Molbio Diagnostics, among others.
- Headquarter Ontario, United States
- Founders Mario Thomas
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Suncity World
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$5 M (USD)
in 1 rounds
-
Latest Funding Round
$5 M (USD), Series A
Jun 02, 2020
-
Investors
NGen
& 1 more
-
Employee Count
Not available
-
Acquired by
SQI Diagnostics
(Feb 14, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Precision Biomonitoring
Precision Biomonitoring offers a comprehensive portfolio of products and services, including Game Bài, Slots Game, Live Game, Bắn Cá, and Thể Thao.
Online platform for traditional card games like poker.
Digital slots with rewards and spinning mechanisms.
Real-time games like sicbo with live dealers.
Shooting games targeting sea creatures for rewards.
Platform for wagering on various sports events.
Funding Insights of Precision Biomonitoring
Precision Biomonitoring has successfully raised a total of $5M through 1 strategic funding round. The most recent funding activity was a Series A round of $5 million completed in June 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Precision Biomonitoring
Precision Biomonitoring has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include NGen and SQI Diagnostics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Advanced manufacturing and technology are advanced by NGen foundation.
|
Locked | Locked | Locked | |
|
Multiplexed tests and automated systems for biological testing are developed.
|
Locked | Locked | Locked |
Investor details for Precision Biomonitoring
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Precision Biomonitoring
Investment portfolio details for Precision Biomonitoring
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Precision Biomonitoring
Detailed financials for Precision Biomonitoring
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Precision Biomonitoring Comparisons
Peer comparison for Precision Biomonitoring
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Precision Biomonitoring
Precision Biomonitoring operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DermTech, NeuMoDx, Biocartis, Biomeme and Molbio Diagnostics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Adhesive patch biopsies for skin cancer detection are provided.
|
|
| Locked | Locked | Locked |
Developer of a platform for low cost molecular testing
|
|
| Locked | Locked | Locked |
Molecular assays for disease detection are developed using proprietary technology.
|
|
| Locked | Locked | Locked |
Smartphone-based DNA detection platform is developed for diagnostics.
|
|
| Locked | Locked | Locked |
Point-of-care molecular platforms for infectious disease detection are developed.
|
|
| Locked | Locked | Locked |
Point-of-care molecular diagnostics are enabled by Ultrafast Photonic PCR technology.
|
Detailed competitors of Precision Biomonitoring
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Precision Biomonitoring
Complete news archive for Precision Biomonitoring
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Precision Biomonitoring
Precision Biomonitoring was founded in 2016 and raised its 1st funding round 4 years after it was founded.
Precision Biomonitoring is headquartered in Ontario, United States. It is registered at Ontario, California, United States.
Mario Thomas is the current CEO of Precision Biomonitoring. They have also founded this company.
Precision Biomonitoring is a funded company, having raised a total of $5M across 1 funding round to date.
Precision Biomonitoring was founded in 2016 and is located in Ontario, United States. Operations focus on the molecular diagnostics sector, where kits and tools are developed for environmental DNA testing of aquatic species and pathogens. The TripleLock platform is employed for definitive species identification. Additionally, a handheld, battery-operated qPCR tool called Biomeme two3 is made available for field applications.
Precision Biomonitoring's top competitors include DermTech, Biocartis and Molbio Diagnostics.
Precision Biomonitoring offers Game Bài, Slots Game, Live Game, Bắn Cá, and Thể Thao.
Precision Biomonitoring has 2 investors. Key investors include NGen, and SQI Diagnostics.